Collaborating across sectors in service of open science, precision oncology, and patients: an overview of the AACR Project GENIE (Genomics Evidence Neoplasia Information Exchange) Biopharma Collaborative (BPC)
Alyssa Acebedo(American Association For Cancer Research), Celeste Yu(University Health Network), Hira Rizvi(Memorial Sloan Kettering Cancer Center), Tony J. Wu(Cancer Research Institute), Xitong Guo(Sage Bionetworks), Samantha Brown(Memorial Sloan Kettering Cancer Center), Julia E. Rudolph, Jason Hoppe(American Association For Cancer Research), E. Alejandro Sweet‐Cordero(University of California, San Francisco), Michele L. Lenoue-Newton(Vanderbilt University Medical Center), Anna B. Newcomb(Dana-Farber Cancer Institute), Philippe L. Bédard(Princess Margaret Cancer Centre), Michael V. Fiandalo(University of Kentucky), Michelle L. Turski(University of California, San Francisco), Asha Postle(Dana-Farber Cancer Institute), R Potter(Vanderbilt University Medical Center), Evelina Ceca(Dana-Farber Cancer Institute), Eva M. Lepisto, Chelsea Nayan(Sage Bionetworks), Shawn M. Sweeney(American Association For Cancer Research), Gregory J. Riely(Memorial Sloan Kettering Cancer Center), Kenneth L. Kehl(Dana-Farber Cancer Institute), Christine Micheel, Thomas Yu(Sage Bionetworks), Brooke Mastrogiacomo(Memorial Sloan Kettering Cancer Center), Brian Piening(Providence College), Hannah E. Fuchs, Jessica A. Lavery(Memorial Sloan Kettering Cancer Center), Deborah Schrag(Dana-Farber Brigham Cancer Center), Chelsea Nichols(Memorial Sloan Kettering Cancer Center), Suresh Pillai(Memorial Sloan Kettering Cancer Center), Ritika Kundra, E. Wingord(University of California, San Francisco), Katherine S. Panageas(Mayo Clinic)
Cited by 4
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Oncogenic Signaling Pathways in The Cancer Genome Atlas
|Cell|2018|3.4k
Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer
|New England Journal of Medicine|2013|3.4k